Stockreport

INmune Bio Inc. Announces 2025 Results and Provides Business Update

INmune Bio Inc. - Common stock  (INMB) 
PDF BOCA RATON, Fla., March 30, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a late-stage biotechnology company focused on inflammation and imm [Read more]